Sign in

CIK 0001894562 · <br>Emerging growth company

Prime Medicine, Inc.

Sign in to watch
Ticker
PRME
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-465-0013
Business address
60 FIRST ST., CAMBRIDGE, MA, 02141
  1. 4 Open-market buy Director bought 800,000 shares at $17.00 ($13,600,000)
  2. 4 Conversion 10% owner acquired 321,665 shares (conversion)
  3. 4 Open-market buy Director bought 400,000 shares at $17.00 ($6,800,000)
  4. 4 Conversion See Remark 1 acquired 8,462,946 shares (conversion)
  5. SC 13G Stake Amended Statement of Ownership
  6. 8-K Event Bylaws or fiscal year change
  7. 3/A Insider 3/A
  8. 424B4 Offering Prospectus
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. FWP Offering Free Writing Prospectus
  13. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  14. EFFECT Other Notice of Effectiveness
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 13 of 16 · 302 filings